Aurisco Pharmaceutical Co Ltd Cash Flow Reinvestment Rate
Aurisco Pharmaceutical Co Ltd cash flow reinvestment rate. Aurisco Pharmaceutical Co Ltd (605116) has a Cash Flow Reinvestment Rate of 3.81x as of December 2024, reinvesting CN¥1.27 Billion (capex CN¥540.28 Million plus investments CN¥-726.77 Million) from operating cash flow of CN¥332.41 Million. Explore Aurisco Pharmaceutical Co Ltd cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Aurisco Pharmaceutical Co Ltd (2017–2024)
Cash flow reinvestment rate of Aurisco Pharmaceutical Co Ltd from 2017 to 2024. Historical reinvestment intensity for Aurisco Pharmaceutical Co Ltd across 8 annual periods. Explore Aurisco Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Aurisco Pharmaceutical Co Ltd Cash Flow Reinvestment Rate by Year (2017–2024)
Aurisco Pharmaceutical Co Ltd cash flow reinvestment rate by year from 2017 to 2024. Year-by-year capital reinvestment analysis for Aurisco Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see 605116 cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.81x | CN¥1.27 Billion | CN¥332.41 Million | CN¥540.28 Million | ▲ +119.1% |
| 2023 | 1.74x | CN¥670.75 Million | CN¥385.61 Million | CN¥305.48 Million | ▼ -38.8% |
| 2022 | 2.84x | CN¥473.01 Million | CN¥166.41 Million | CN¥216.23 Million | ▲ +11.7% |
| 2021 | 2.54x | CN¥512.96 Million | CN¥201.57 Million | CN¥250.61 Million | ▲ +72.8% |
| 2020 | 1.47x | CN¥315.81 Million | CN¥214.48 Million | CN¥158.80 Million | ▲ +71.4% |
| 2019 | 0.86x | CN¥154.57 Million | CN¥179.90 Million | CN¥72.47 Million | ▲ +0.2% |
| 2018 | 0.86x | CN¥94.14 Million | CN¥109.77 Million | CN¥94.14 Million | ▼ -5.1% |
| 2017 | 0.90x | CN¥106.60 Million | CN¥117.91 Million | CN¥106.60 Million | — |